Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...
When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even ...
Brett A. Wall, Executive Vice President and President of Neuroscience at Medtronic plc (NYSE:MDT), a $118 billion market cap ...
chief medical officer of the Diabetes Group at Medtronic. "The data demonstrating the benefits of this system are compelling and I'm confident it will simplify diabetes care for both patients and ...
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
Peralta will be responsible for leading worldwide manufacturing operations, including driving alignment of operations with ...
Medtronic has several products, such as AiBLE (spinal implants) and Percept (brain modulation), that have been getting adopted Its diabetes segment, while the smallest business (about 8% of ...
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Medtronic (MDT – Research Report). The company’s ...